In early January 2026, Teleflex announced the past departure of Chairman, President and CEO Liam Kelly, appointed long-time ...

Teleflex announced a major leadership transition effective January 7–8, 2026, with long-time Chairman, President and CEO Liam Kelly departing and board member Stuart Randle, a veteran medical device ...

Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two separate deals totalling over $2bn as part of the company’s broader portfolio ...

The company now expects 2025 adjusted constant currency growth of 6.9% to 7.4%. Adjusted revenue growth guidance for 2025 is now 8% to 8.5%, down from the prior 8.5% to 9.5%, with a revenue dollar ...